Concerns Over Electroconvulsive Therapy Grow as New Research Reveals Wider Range of Adverse Effects
A recent study has raised concerns about the long-term safety and efficacy of electroconvulsive therapy (ECT), a treatment used to treat severe depression and other mental health conditions. The research, which surveyed 747 ECT patients and 201 relatives and friends, found that nearly a quarter of participants experienced heart problems, including arrhythmia, after undergoing the procedure.
While short- and long-term memory loss is widely known as a result of ECT, the new study identified 25 additional concerning side effects, including cardiovascular problems, fatigue, and emotional blunting. These findings have led experts to call for the practice to be suspended pending more robust research into its safety and efficacy.
The study's author, Professor John Read, warned that the lack of conclusive evidence on ECT's effectiveness makes it difficult to justify continued use. "Given that we still don't know if ECT is more effective than placebo, these startling new findings make it even more urgent that it be suspended pending a thorough investigation into both safety and efficacy," he said.
The research also found that nearly three-quarters of participants experienced emotional blunting, with some experiencing relationship problems, difficulty navigating, and loss of vocabulary. The study's authors caution that ECT should not be seen as a "complete cure" but rather one treatment option among many.
Despite the concerns raised by this study, some experts argue that ECT can be an effective tool in managing acute symptoms and reducing risks associated with other treatments. However, they also emphasize the need for more research to understand and minimize potential side effects, such as autobiographical memory loss and gaps from periods of life close to treatment.
As the debate around ECT continues, advocates are pushing for stronger regulation and greater transparency about its use. A recent study found that many people were unaware that ECT was still performed as a treatment, with one-third receiving it against their will. The National Institute for Health and Care Excellence (Nice) has guidelines in place to ensure clinicians carefully consider the risks and benefits of ECT before administering it.
The controversy surrounding ECT highlights the need for ongoing research and discussion about mental health treatments. As experts continue to weigh the potential benefits and risks, patients and families must remain informed and advocate for their rights.
A recent study has raised concerns about the long-term safety and efficacy of electroconvulsive therapy (ECT), a treatment used to treat severe depression and other mental health conditions. The research, which surveyed 747 ECT patients and 201 relatives and friends, found that nearly a quarter of participants experienced heart problems, including arrhythmia, after undergoing the procedure.
While short- and long-term memory loss is widely known as a result of ECT, the new study identified 25 additional concerning side effects, including cardiovascular problems, fatigue, and emotional blunting. These findings have led experts to call for the practice to be suspended pending more robust research into its safety and efficacy.
The study's author, Professor John Read, warned that the lack of conclusive evidence on ECT's effectiveness makes it difficult to justify continued use. "Given that we still don't know if ECT is more effective than placebo, these startling new findings make it even more urgent that it be suspended pending a thorough investigation into both safety and efficacy," he said.
The research also found that nearly three-quarters of participants experienced emotional blunting, with some experiencing relationship problems, difficulty navigating, and loss of vocabulary. The study's authors caution that ECT should not be seen as a "complete cure" but rather one treatment option among many.
Despite the concerns raised by this study, some experts argue that ECT can be an effective tool in managing acute symptoms and reducing risks associated with other treatments. However, they also emphasize the need for more research to understand and minimize potential side effects, such as autobiographical memory loss and gaps from periods of life close to treatment.
As the debate around ECT continues, advocates are pushing for stronger regulation and greater transparency about its use. A recent study found that many people were unaware that ECT was still performed as a treatment, with one-third receiving it against their will. The National Institute for Health and Care Excellence (Nice) has guidelines in place to ensure clinicians carefully consider the risks and benefits of ECT before administering it.
The controversy surrounding ECT highlights the need for ongoing research and discussion about mental health treatments. As experts continue to weigh the potential benefits and risks, patients and families must remain informed and advocate for their rights.